ClinicalTrials.gg
Sign In

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating clinical trials

The registry lists 137 studies for Polyradiculoneuropathy, Chronic Inflammatory Demyelinating across more than 10 countries. 51 are recruiting or about to start. 108 of them are mainly about Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Polyradiculoneuropathy, Chronic Inflammatory Demyelinating studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
51
Recruiting
36
Not yet recruiting
11
Terminated
11
Active, not recruiting
9
Status unknown
8

Phase

Phase 3
31
Phase 2
28
Phase 1
8
Early Phase 1
5
Phase 4
5

Where

United States
55
France
38
Germany
35
Italy
28
Denmark
24
United Kingdom
23

Who runs them

argenx (9) · CSL Behring (6) · University of Aarhus (6) · Takeda (5) · Tongji Hospital (5) · Sanofi (4) · Centre Hospitalier Universitaire de Nice (3) · National Center for Research Resources (NCRR) (3)

What is being tested here

Drugs under test in Polyradiculoneuropathy, Chronic Inflammatory Demyelinating studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Empasiprubart333
Immunoglobulin G2711
Immunoglobulins, Intravenous259
Immunoglobulins268
Riliprubart234
Rituximab125
Ripertamab111
Nipocalimab111
Claseprubart111
Autologous Anti-CD19/CD20 CAR-T Cells KITE-363101

Coming up

13phase 3 studies under way
24studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 36 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating studies recruiting now, 24 (67%) set no upper age limit and 9 (25%) stop at 75 or younger. 4 (11%) take children under 18. 1 (3%) are for women only and 0 (0%) for men only; 2 (6%) take healthy volunteers.

Recruiting studies that take each age, of 36
AgeWomenMen
103 (8%)2 (6%)
1835 (97%)34 (94%)
3035 (97%)34 (94%)
4035 (97%)34 (94%)
5035 (97%)34 (94%)
6534 (94%)33 (92%)
7532 (89%)31 (86%)
8526 (72%)25 (69%)

Across all 137 studies, recruiting or not: 18% stop at 75 or younger and 8% at 65; 10% take children; 1% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 137. Browse all 137 → or search them.